Clinical Trials Browser

Phase 1/2 × Lymphoma, Follicular × Temozolomide × Clear all

NCT05765812 2026-02-27

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Phase 1/2 Recruiting

Astrocytoma, Glioblastoma, Lymphoma, Follicular

NCT02590263 2020-09-03

Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma

Phase 1/2 Completed

Glioblastoma, Glioma, Lymphoma, Follicular